rilpivirinum 600 mg, poloxamerum 338, glucosum monohydricum, natrii dihydrogenophosphas monohydricus, acidum citricum monohydricum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 2 ml corresp. natrium 1.66 mg.
Packungsbestandteile
Depot-Injektionssuspension
Active Agent
Dose
Rilpivirinum
600mg / 2ml
Inactive agents
Dose
Citric Acid Monohydrate
Glucose Monohydrate
Sodium Dihydrogenophosphate Monohydrate
Sodium Hydroxide
Poloxamer
338
Source
Data was imported : 04.12.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
